APA Citatie

Caplin, M. E., Pavel, M., Ćwikła, J. B., Phan, A. T., Raderer, M., Sedláčková, E., . . . Ruszniewski, P. (2016). Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: The CLARINET open-label extension study. Endocr Relat Cancer.

Chicago Style citaat

Caplin, Martyn E., et al. "Anti-tumour Effects of Lanreotide for Pancreatic and Intestinal Neuroendocrine Tumours: The CLARINET Open-label Extension Study." Endocr Relat Cancer 2016.

MLA citatie

Caplin, Martyn E., et al. "Anti-tumour Effects of Lanreotide for Pancreatic and Intestinal Neuroendocrine Tumours: The CLARINET Open-label Extension Study." Endocr Relat Cancer 2016.